93 related articles for article (PubMed ID: 7871780)
1. [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli].
Cheng Y; Li Y; Chen M
Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):360-6. PubMed ID: 7871780
[TBL] [Abstract][Full Text] [Related]
2. [A plasmid-mediated SHV type extended-spectrum beta-lactamase in Beijing isolate of Enterobacter gergoviae].
Cheng Y; Li Y; Chen M
Wei Sheng Wu Xue Bao; 1994 Apr; 34(2):106-12. PubMed ID: 8073758
[TBL] [Abstract][Full Text] [Related]
3. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
Subramaniam G; Palasubramaniam S; Navaratnam P
Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
[TBL] [Abstract][Full Text] [Related]
4. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
Chouchani C; Ben-Achour N; M'charek A; Belhadj O
C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
[TBL] [Abstract][Full Text] [Related]
5. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
7. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
8. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
Aktaş Z; Gönüllü N; Schneider I; Bal C; Bauernfeind A
Mikrobiyol Bul; 2005 Oct; 39(4):421-9. PubMed ID: 16544543
[TBL] [Abstract][Full Text] [Related]
9. CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.
Robin F; Delmas J; Archambaud M; Schweitzer C; Chanal C; Bonnet R
Antimicrob Agents Chemother; 2006 Jul; 50(7):2403-8. PubMed ID: 16801418
[TBL] [Abstract][Full Text] [Related]
10. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
11. [Transferrable broad-spectrum beta-lactam resistance in Klebsiella pneumoniae R-3455].
Conde-Bonfil MC; Silva J; Ovando C; Becerra Z; González V; Fuchs Y
Rev Latinoam Microbiol; 1993; 35(3):237-43. PubMed ID: 8047726
[TBL] [Abstract][Full Text] [Related]
12. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
[TBL] [Abstract][Full Text] [Related]
13. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
Esposito S; Galante D; Barba D; Pennucci C; Limauro D
Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
[TBL] [Abstract][Full Text] [Related]
14. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate.
Perilli M; Mugnaioli C; Luzzaro F; Fiore M; Stefani S; Rossolini GM; Amicosante G
Antimicrob Agents Chemother; 2005 Apr; 49(4):1564-6. PubMed ID: 15793140
[TBL] [Abstract][Full Text] [Related]
15. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
18. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Bethel CR; Hujer AM; Helfand MS; Bonomo RA
FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
[TBL] [Abstract][Full Text] [Related]
19. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
[TBL] [Abstract][Full Text] [Related]
20. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
